These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36455903)

  • 21. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
    Marian AJ; Braunwald E
    Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertrophic cardiomyopathy: infants, children, and adolescents.
    Maskatia SA
    Congenit Heart Dis; 2012; 7(1):84-92. PubMed ID: 22222117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of recent advances in the management of hypertrophic cardiomyopathy.
    Cao Y; Zhang PY
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5207-5210. PubMed ID: 29228435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction.
    Behrens-Gawlik V; Mearini G; Gedicke-Hornung C; Richard P; Carrier L
    Pflugers Arch; 2014 Feb; 466(2):215-23. PubMed ID: 24337823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial hypertrophic cardiomyopathy: from mutations to functional defects.
    Bonne G; Carrier L; Richard P; Hainque B; Schwartz K
    Circ Res; 1998 Sep; 83(6):580-93. PubMed ID: 9742053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.
    D'Andrea A; Caso P; Cuomo S; Salerno G; Scarafile R; Mita C; De Corato G; Sarubbi B; Scherillo M; Calabrò R
    Br J Sports Med; 2006 Mar; 40(3):244-50; discussion 244-50. PubMed ID: 16505082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic screening of patients with hypertrophic cardiomyopathy--a new diagnostic strategy for risk stratification?
    Hudecova K; Simkova I; Gardlik R; Bernadic M
    Bratisl Lek Listy; 2009; 110(2):85-92. PubMed ID: 19408839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers.
    Marian AJ
    Clin Cardiol; 1995 Apr; 18(4):189-98. PubMed ID: 7788945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertrophic cardiomyopathy.
    Maron BJ; Maron MS
    Lancet; 2013 Jan; 381(9862):242-55. PubMed ID: 22874472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of disease: hypertrophic cardiomyopathy.
    Frey N; Luedde M; Katus HA
    Nat Rev Cardiol; 2011 Oct; 9(2):91-100. PubMed ID: 22027658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertrophic cardiomyopathy].
    van Driel B; Asselbergs FW; de Boer RA; van Rossum AC; van Tintelen JP; van der Velden J; Michels M
    Ned Tijdschr Geneeskd; 2019 Feb; 163():. PubMed ID: 30730688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the population for gene therapy with MYBPC3.
    Carrier L
    J Mol Cell Cardiol; 2021 Jan; 150():101-108. PubMed ID: 33049255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevention of sudden death in hypertrophic cardiomyopathy.
    Sachdev B; Hamid MS; Elliott PM
    Expert Opin Pharmacother; 2002 May; 3(5):499-504. PubMed ID: 11996628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Rosmini S; Biagini E; O'Mahony C; Bulluck H; Ruozi N; Lopes LR; Guttmann O; Reant P; Quarta CC; Pantazis A; Tome-Esteban M; Mckenna WJ; Rapezzi C; Elliott PM
    Heart; 2017 Feb; 103(4):300-306. PubMed ID: 27798053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and significance of preclinical diagnosis in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED; Hadjimiltiades S; Meditskou S; Karvounis H; McKenna WJ
    Cardiol Rev; 2015; 23(6):297-302. PubMed ID: 26440533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):212-216. PubMed ID: 31004609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Athlete's heart or hypertrophic cardiomyopathy?
    Lauschke J; Maisch B
    Clin Res Cardiol; 2009 Feb; 98(2):80-8. PubMed ID: 18853091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.
    Gaertner-Rommel A; Tiesmeier J; Jakob T; Strickmann B; Veit G; Bachmann-Mennenga B; Paluszkiewicz L; Klingel K; Schulz U; Laser KT; Karger B; Pfeiffer H; Milting H
    Mol Genet Genomic Med; 2019 Aug; 7(8):e841. PubMed ID: 31293105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.